AAPL
53
3
AN
65
2
MMC
58
-4
AMT
24
-4
TDC
75
-3
OI
54
2
CCI
15
-2
ADSK
67
2
SPG
51
-12
C
84
3
CAT
57
2
MAT
65
2
PNC
75
4
MA
72
-2
MRK
38
-8
WAT
55
-4
SE
88
3
OKE
55
5
CAG
41
-2
CB
51
-6
AAPL
53
3
AN
65
2
MMC
58
-4
AMT
24
-4
TDC
75
-3
OI
54
2
CCI
15
-2
ADSK
67
2
SPG
51
-12
C
84
3
CAT
57
2
MAT
65
2
PNC
75
4
MA
72
-2
MRK
38
-8
WAT
55
-4
SE
88
3
OKE
55
5
CAG
41
-2
CB
51
-6
Financhill
Back

Alkermes PLC 10K Form

Sell
47

ALKS
Alkermes PLC

Last Price:
$30.62
Seasonality Move:
6.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q ALKS/Alkermes PLC Quarterly
2023-10-25 10Q ALKS/Alkermes PLC Quarterly
2023-07-26 10Q ALKS/Alkermes PLC Quarterly
2023-04-26 10Q ALKS/Alkermes PLC Quarterly
2022-11-02 10Q ALKS/Alkermes PLC Quarterly
2022-07-27 10Q ALKS/Alkermes PLC Quarterly

Receive ALKS News And Ratings

See the #1 stock for the next 7 days that we like better than ALKS

ALKS Financial Statistics

Sales & Book Value

Annual Sales: $1.6B
Cash Flow: $88.7M
Price / Cash Flow: 10.77
Annual Sales: $9.17
Price / Book: 3.36

Profitability

EPS (TTM): 2.09000
Net Income (TTM): $352.7M
Gross Margin: $1.3B
Return on Equity: 25.91%
Return on Assets: 16.6%

Alkermes PLC Earnings Forecast

Key Alkermes PLC Financial Ratios

  • The Gross Profit Margin over the past 33 years for ALKS is 84.25%.
  • The Selling, General & Administrative Expenses for ALKS have been equal to 41.42% of Gross Profit Margin.
  • The Research & Development expenses have been 15.75% of Revenue.
  • The Interest Expense is 6.15% of Operating Income.
  • The Net Earning history of ALKS is 23.57% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 17 years.

Alkermes PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALKS
CUSIP: G01767
Website: alkermes.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.33
Quick Ratio: 2.72

Price-to-Earnings

Trailing P/E Ratio: 14.21
Forward P/E Ratio: 17.44

ALKS Technical Analysis vs Fundamental Analysis

Sell
47
Alkermes PLC (ALKS) is a Sell

Is Alkermes PLC a Buy or a Sell?

  • Alkermes PLC stock is rated a Sell
    The current Alkermes PLC [ALKS] share price is $30.84. The Score for ALKS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.